Accelrys Inc (ACCL) 12.50 $ACCL
New ScienceCloud Mobile Applications by Accelrys Drive Collaborative Drug Discovery
PR Newswire - Thu Apr 17, 7:00AM CDT
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software and solutions, today announced the availability of two new mobile applications supporting key life sciences workflows and real-time collaboration spanning both the ScienceCloud workspace and on-premises systems. ScienceCloud is a secure, SaaS-based, mobile-enabled information management and collaboration environment that improves data and knowledge sharing for globally networked researchers. Bi-directional integration between ScienceCloud and existing on-premises systems lets life sciences organizations migrate to the cloud in a measured fashion, continuing to leverage critical legacy applications as long as needed.
Global Laboratory Information Systems (LIS / LIMS) Market 2017 - Clinical Laboratory Software and Hardware, Drug Discovery Systems
M2 - Wed Apr 16, 5:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/644b9v/laboratory) has announced the addition of the "Laboratory Information Systems (LIS / LIMS) Markets - Clinical Laboratory Software and Hardware, Drug Discovery Systems" report to their offering. The market for laboratory information management systems will grow to nearly a $1.5 billion market in 2015. The healthcare market research firm said growth would be spurred on by the desire of clinical diagnostic laboratories to handle larger amounts of data from molecular testing and sequencing. Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and medical-related laboratories, including clinical and analytical laboratories. The World Market for Lab Information Systems (LIS) analyzes the current and potential world markets for medical laboratory information system software and hardware - both for the clinical diagnostics lab and the drug discovery and research laboratory. This report forecasts future growth to 2017. Market segments covered include the world, North American, European, Brazilian and Japanese markets, as well as segments for LIS software and hardware. As part of its coverage, the report contains the following: - Clinical LIMS Market in North America, Europe, Brazil, Japan, Rest of World - Drug Discovery LIMS Market in North America, Europe, Brazil, Japan, Rest of World - Recent Key Mergers and Acquisitions - Laboratory Types and Growth - Laboratory Information Systems Selected Vendors, Approximate Number of Contracts/Operating Sites - Software Markets - Hardware Markets - Service Markets - Drivers and Obstacles to Growth This report also reviews the nature and direction of research and trends, and gives insight into some issues facing the industry. Among these trends are the following: - Accelrys Acquires Aegis, Vialis - Roper Acquires Sunquest - StarLims Acquires Distributors - On-Demand LIMS - Toxicology LIS - HIPAA 5010 Migration - Multi-Groups Capability - Middleware Platform - Cerner Expands with Labotix Acquisition - Next-Generation Sequencing - Proof of Concept Service Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction Chapter Three: Trends And Issues Chapter Four: Recent Market Developments Chapter Five: Markets Chapter Six: Corporate Profiles - AAC Infotray AG - Accelrys Inc - Accelerated Technology Laboratories Inc - AJ Blomesystem GmbH - ASM Soft SL - Autoscribe - CambridgeSoft - Cerner Corp - ChemWare Inc - Clinical Software Solutions - Data Unlimited International Inc. - Desarrollo Aplicaciones Sanitarias SL - eBioSys Pty Ltd - Elekta AB - Kriti Microsystems Pvt. Ltd - LabLogic Systems Ltd - LabVantage Solutions Inc - LabWare Inc - LIMS at Work GmbH - McKesson Technology Solutions - Modul-Bio - Orchard Software Corp - PathCentral - Polisystem Informatica Srl - Siemens Healthcare - Swisslab GmbH - Tainosystems - Technidata - Thermo Fisher Scientific - Visual Access Health Systems Pvt. Ltd For more information visit http://www.researchandmarkets.com/research/644b9v/laboratory
Accelrys Up 33.3% Since SmarTrend Uptrend Call (ACCL)
Comtex SmarTrend(R) - Tue Apr 15, 11:04AM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 7 months, Accelrys has returned 33.26% as of today's recent price of $12.48.
In Vitro Toxicity Testing to Grow at a 15.84% CAGR to 2018 Says a New Research Report at ReportsnReports.com
PRWeb - Mon Apr 14, 2:58AM CDT
Cosmetic as well as chemical companies are trying to market and sell their products by campaigning animal-free testing. Popular brands of cosmetics are implementing animal-free testing policies to market and sell their products. Vendors are targeting compassionate consumers by marketing their products as Cruelty-free food Cosmetics And clothing as cruelty-free testing does not damage the environment or produce harmful waste. Analysts forecast the Global In Vitro Toxicity Testing market will grow at a CAGR of 15.84 percent over the period 2013-2018. According to the report, the Global In Vitro Toxicity Testing market is driven by several factors, of which an increase in opposition to animal testing is one of the major drivers. Since animals are used as test subjects, toxicity testing is opposed by the majority of animal rights activists. This results in the increased adoption of in vitro toxicity testing and helps in the growth of the market. Covered in this Report The Global In Vitro Toxicity Testing market can be divided into four end-user segments: Cosmetics and Personal Care Industry, Pharmaceuticals Industry, Food Industry, and Chemicals Industry. The Global In Vitro Toxicity Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the market. In addition, the report discusses the major drivers that influence the growth of the Global In Vitro Toxicity Testing market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. The report also includes a discussion of the key vendors operating in this market. Key Regions Americas EMEA APAC Key Vendors Accelrys Inc. Bio-Rad Laboratories Inc. Charles River Laboratories International Inc. Covance Inc. Purchase Report @ http://www.reportsnreports.com/purchase.aspx?name=280671. Other Prominent Vendors Entelos Inc. Mattek Corp. Molecular Toxicology Inc. RTI Health Solutions SBW Ltd. Smithers Group Inc. Xenobiotic Detection Systems Inc. Xenometrix AG Key Market Driver Increasing Opposition to Animal Testing. Key Market Challenge Concerns about Accuracy and Reliability of the Test. Key Market Trend Increase in Animal-free Testing Campaigns. Further, the report states that the accuracy and reliability of in vitro toxicity testing is one of the major challenges faced by the market vendors. In vitro toxicity testing requires proper laboratory setup as well as high-quality cell and tissue culture and good aseptic techniques. The report recognizes the following companies as the key players in Global In-vitro Toxicity Testing Market: Accelrys Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International Inc. , Covance Inc. , Entelos Inc., MattekCorp., Molecular Toxicology Inc., RTI Health Solutions, SBW Ltd., Smithers Group Inc., Xenobiotic Detection SystemsInc., Xenometrix AG. Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Accelrys® Speeds Life Science Decisions with Next-Generation Insight®
PR Newswire - Thu Apr 10, 7:00AM CDT
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software and solutions, today announced the latest releases of Accelrys Insight and Accelrys Insight for Excel. The new release of Accelrys Insight for Excel enhances scientific data analysis with important new capabilities including the ability to run database searches directly from the familiar Microsoft Excel spreadsheet environment. The new release of the web-based Accelrys Insight life science, discovery and innovation support environment speeds decisions by simplifying access to complex hierarchical data and implementing data-rich tooltips for scatterplots. The two releases continue the rapid evolution of Accelrys' next-generation solution for interactively searching, browsing and visualizing data within the Accelrys Cheminformatics Suite, helping networked life science discovery teams bring innovative therapeutics to market faster and more cost effectively. Both products leverage the open, scientifically aware Accelrys Enterprise Platform which provides a single consistent way for applications to access both internal data and public data accessible via web services.
Dassault Systemes announces extension of tender offer for Accelrys' shares until 22 April 2014
M2 - Wed Apr 09, 11:07AM CDT
Dassault Systemes (Paris
SY.PA), a provider of 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, today announced the extension of the tender offer by its wholly owned indirect subsidiary, 3DS Acquisition Corp, to purchase all outstanding shares of Accelrys Inc (Nasdaq:ACCL) common stock until midnight, New York City time of 22 April 2014, unless otherwise extended or terminated.
Dassault Systemes Extends Tender Offer for Accelrys until April 22, 2014
Business Wire - Wed Apr 09, 12:19AM CDT
Regulatory News:
Shares of ACCL Up 33.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 08, 9:40AM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 7 months, Accelrys has returned 33.26% as of today's recent price of $12.48.
Biosimulation Trends - Global Market Overview 2014-2017
M2 - Thu Apr 03, 10:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bclc3f/biosimulation) has announced the addition of the "Biosimulation Trends" report to their offering. Biosimulation is the mathematical simulation of complex, large biological processes on a computer. Biosimulation is being adopted at a faster pace, to extract and interpret vital data from experiments during drug discovery and development. The report analyzes and presents an overview of Biosimulation market worldwide. The report provides global market estimates and projections for Biosimulation in US dollars for the years 2012 through 2017. Supported with 1 market data table, the report highlights the ever increasing permanence of Biosimulation. The report also provides a review of Biosimulation Models, and Biosimulation software. Key Topics Covered: 1. BIOSIMULATION - A MARKET OVERVIEW - A Prelude - Biosimulation - Revolutionizing Drug Discovery - Biosimulation - Models - Biosimulation Software 2. RECENT INDUSTRY ACTIVITY - Accelrys Introduces Discovery Studio 3.5 - Rhenovia Pharma Introduces Drug Development Programs for Orphan, Neglected and Rare Neurodegenerative Diseases - Rhenovia Pharma Sets Up International Subsidiary in the US - Rhenovia Pharma Inks an Agreement with Portmann - Entelos and RegeneMed Introduce iToxFX Service 3. MARKET PARTICIPANTS - Accelrys, Inc. - Advanced Chemistry Development, Inc. - Anoixis Corporation - Aptiv Solutions - Chemical Computing Group, Inc. - Cognigen Corporation - Compugen Ltd. - Entelos, Inc. - Genedata AG - GNS Healthcare - Immunetrics, Inc. - INOSIM Software GmbH - Insilico Biotechnology AG - Kinetigen, Inc. - LeadInvent - Leadscope, Inc. - Molecular Knowledge Systems, Inc. - Nimbus Discovery LLC - Novo Nordisk A/S - Open Eye Scientific Software, Inc. - Optimata Ltd. - PhinC Development - Physiomics PLC - Rhenovia Pharma SAS - Rosa & Company LLC - Schrodinger LLC - Simcyp Ltd. - Tessella Ltd. - TheraSim - VirtuCel, Inc. 4. APPENDIX For more information visit http://www.researchandmarkets.com/research/bc...simulation
Alliance Fiber Optic Products (AFOP) Surges: Stock Moves 12.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 8:18AM CDT
Alliance Fiber Optic Products Inc. (AFOP) was a big mover last session, as the company saw its shares rise by roughly 13% on the day.
Latin American Bioinformatics Market by Sector, Segment & Applications - Forecasts to 2017
M2 - Tue Apr 01, 8:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kss73x/latin_american) has announced the addition of the "Latin American Bioinformatics Market by Sector, Segment & Application - Forecasts to 2017" report to their offering. The Latin American bioinformatics market displays a lucrative growth potential. It is estimated to grow at a CAGR of 22% from 2012 to 2017 to reach $627 million by 2017 In Latin America, bioinformatics is now widely recognized as a crucial field for research and development in agricultural, veterinary, and human health sciences. The growth of the bioinformatics market is driven by factors such as the decreasing cost of DNA sequencing, the increasing number of training and development programs on the usage of bioinformatics tools/platforms, the high concentration of bioinformatics research institutes, ongoing partnerships of academic institutions, and the formation of regional bioinformatics networks. However, the dearth of adequate infrastructural facilities and skilled professionals, presence of obsolete bioinformatics solutions, lack of government funding and investments, and less focus of global bioinformatics players on Latin American countries are factors that are restraining the growth of the market. Based on the use of bioinformatics in various industries, the bioinformatics market is segmented into agriculture, medical, environment, forensic, academics, and others (including homeland security and defense, law-enforcement groups, bioweapon creation, antibiotic resistance, and evolutionary biotechnology). The medical biotechnology market is segmented into molecular medicine, clinical diagnostics, drug development, gene therapy, and reproductive biotechnology. On the other hand, agriculture biotechnology is segmented into crop yield improvement, insect and disease resistance, nutritional quality improvement, soil quality improvement, improvement of plant resistance against abiotic stress, and others. Furthermore, the environmental biotechnology market includes waste cleanup, alternative energy sources, climate change studies, forensics biotechnology, and others. Based on the type of products and services, the bioinformatics market is classified into knowledge management tools, platforms, and services. The bioinformatics knowledge management tools market includes generalized and specialized knowledge management tools. The bioinformatics platforms market is segmented into sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms, structural and functional analysis platforms, and others. The bioinformatics services market comprises sequencing services, database management, data analysis, and others. The bioinformatics market has several practical applications in fields that generate large data sets. In this report, the various applications of bioinformatics include genomics, proteomics, chemoinformatics, molecular phylogenies, metabolomics, transcriptomics, and others. Brazil was the largest market in 2012 with 40% share of the Latin American bioinformatics market, followed by Mexico. However, Chile and Peru represent the fastest-growing markets due to the initiatives taken by these nations with regards to skills development of researchers as well as the ongoing academic collaborations to facilitate the adoption of bioinformatics in life sciences research. The major players in the bioinformatics industry include Agilent Technologies, Inc. (U.S.), Affymetrix, Inc. (U.S.), Life Technologies Corporation (U.S.), Illumina, Inc. (U.S.), and CLC Bio (Denmark). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Latin America Bioinformatics Market, By Sectors 6 Latin America Bioinformatics Market, By Products & Services 7 Latin America Bioinformatics Market, By Applications 8 Geographic Analysis 9 Company Profiles - Accelrys, Inc. - Active Motif, Inc. - Affymetrix, Inc. - Agilent Technologies, Inc. - Clc Bio - Geneva Bioinfromatics (Genebio) Sa - Illumina, Inc. - Life Technologies Corporation - Partek, Incorporated - Perkinelmer, Inc. For more information visit http://www.researchandmarkets.com/research/ks...n_american
What Makes IntraLinks Holdings (IL) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 7:52AM CDT
IntraLinks Holdings has witnessed a significant price decline in the past four weeks. The reason is negative trend in earnings estimate revisions. The stock also has seen some pretty dismal trading lately.
Dr. David B. Agus to Present Keynote Address on the End of Illness at Accelerate2014
PR Newswire - Thu Mar 27, 4:40PM CDT
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software and solutions, today announced that David B. Agus, MD, one of the world's leading cancer doctors, researchers, medical futurists and technology innovators, will present the keynote address at the Accelrys user conference, Accelerate2014, which is being held from May 19-23 at the Grand Hyatt Washington, D.C.
Strength Seen in Elephant Talk Communications (ETAK): Stock Up 18.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 8:04AM CDT
Elephant Talk Communications Corp. was a big mover last session, as the company saw its shares rise by nearly 19% on the day.
Dassault Systemes extends offer for Accelrys
M2 - Thu Mar 27, 7:43AM CDT
Dassault Systemes (DSY.PA) said it has extended the tender offer by its subsidiary, 3DS Acquisition Corp., to purchase all outstanding shares of Accelrys, Inc. (NASDAQ: ACCL) common stock at an offer price of USD12.50 per share in cash.
33.5% Return Seen to Date on SmarTrend Accelrys Call (ACCL)
Comtex SmarTrend(R) - Mon Mar 24, 4:56PM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 6 months, Accelrys has returned 33.48% as of today's recent price of $12.50.
Biogen Idec to Present on Best Practices for Leveraging Quality and Regulatory Compliance Management Software on Apple iPads
Marketwire - Thu Mar 20, 8:00AM CDT
QUMAS, an Accelrys company (NASDAQ: ACCL), today announced that it will host a live, complimentary webinar highlighting how to save time, money, and materials and how to increase compliance across Manufacturing by leveraging QUMAS Quality and Regulatory Compliance Management Software on Apple iPads. The webinar will offer expert advice from Gregory Chua, Senior Manufacturing Support Associate at Biogen Idec and Murtuza Vasowalla, Director of Global Solutions Consulting at QUMAS.
New ScienceCloud Mobile Applications by Accelrys Drive Collaborative Drug Discovery
PR Newswire - Thu Apr 17, 7:00AM CDT
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software and solutions, today announced the availability of two new mobile applications supporting key life sciences workflows and real-time collaboration spanning both the ScienceCloud workspace and on-premises systems. ScienceCloud is a secure, SaaS-based, mobile-enabled information management and collaboration environment that improves data and knowledge sharing for globally networked researchers. Bi-directional integration between ScienceCloud and existing on-premises systems lets life sciences organizations migrate to the cloud in a measured fashion, continuing to leverage critical legacy applications as long as needed.
Global Laboratory Information Systems (LIS / LIMS) Market 2017 - Clinical Laboratory Software and Hardware, Drug Discovery Systems
M2 - Wed Apr 16, 5:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/644b9v/laboratory) has announced the addition of the "Laboratory Information Systems (LIS / LIMS) Markets - Clinical Laboratory Software and Hardware, Drug Discovery Systems" report to their offering. The market for laboratory information management systems will grow to nearly a $1.5 billion market in 2015. The healthcare market research firm said growth would be spurred on by the desire of clinical diagnostic laboratories to handle larger amounts of data from molecular testing and sequencing. Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and medical-related laboratories, including clinical and analytical laboratories. The World Market for Lab Information Systems (LIS) analyzes the current and potential world markets for medical laboratory information system software and hardware - both for the clinical diagnostics lab and the drug discovery and research laboratory. This report forecasts future growth to 2017. Market segments covered include the world, North American, European, Brazilian and Japanese markets, as well as segments for LIS software and hardware. As part of its coverage, the report contains the following: - Clinical LIMS Market in North America, Europe, Brazil, Japan, Rest of World - Drug Discovery LIMS Market in North America, Europe, Brazil, Japan, Rest of World - Recent Key Mergers and Acquisitions - Laboratory Types and Growth - Laboratory Information Systems Selected Vendors, Approximate Number of Contracts/Operating Sites - Software Markets - Hardware Markets - Service Markets - Drivers and Obstacles to Growth This report also reviews the nature and direction of research and trends, and gives insight into some issues facing the industry. Among these trends are the following: - Accelrys Acquires Aegis, Vialis - Roper Acquires Sunquest - StarLims Acquires Distributors - On-Demand LIMS - Toxicology LIS - HIPAA 5010 Migration - Multi-Groups Capability - Middleware Platform - Cerner Expands with Labotix Acquisition - Next-Generation Sequencing - Proof of Concept Service Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction Chapter Three: Trends And Issues Chapter Four: Recent Market Developments Chapter Five: Markets Chapter Six: Corporate Profiles - AAC Infotray AG - Accelrys Inc - Accelerated Technology Laboratories Inc - AJ Blomesystem GmbH - ASM Soft SL - Autoscribe - CambridgeSoft - Cerner Corp - ChemWare Inc - Clinical Software Solutions - Data Unlimited International Inc. - Desarrollo Aplicaciones Sanitarias SL - eBioSys Pty Ltd - Elekta AB - Kriti Microsystems Pvt. Ltd - LabLogic Systems Ltd - LabVantage Solutions Inc - LabWare Inc - LIMS at Work GmbH - McKesson Technology Solutions - Modul-Bio - Orchard Software Corp - PathCentral - Polisystem Informatica Srl - Siemens Healthcare - Swisslab GmbH - Tainosystems - Technidata - Thermo Fisher Scientific - Visual Access Health Systems Pvt. Ltd For more information visit http://www.researchandmarkets.com/research/644b9v/laboratory
Accelrys Up 33.3% Since SmarTrend Uptrend Call (ACCL)
Comtex SmarTrend(R) - Tue Apr 15, 11:04AM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 7 months, Accelrys has returned 33.26% as of today's recent price of $12.48.
In Vitro Toxicity Testing to Grow at a 15.84% CAGR to 2018 Says a New Research Report at ReportsnReports.com
PRWeb - Mon Apr 14, 2:58AM CDT
Cosmetic as well as chemical companies are trying to market and sell their products by campaigning animal-free testing. Popular brands of cosmetics are implementing animal-free testing policies to market and sell their products. Vendors are targeting compassionate consumers by marketing their products as Cruelty-free food Cosmetics And clothing as cruelty-free testing does not damage the environment or produce harmful waste. Analysts forecast the Global In Vitro Toxicity Testing market will grow at a CAGR of 15.84 percent over the period 2013-2018. According to the report, the Global In Vitro Toxicity Testing market is driven by several factors, of which an increase in opposition to animal testing is one of the major drivers. Since animals are used as test subjects, toxicity testing is opposed by the majority of animal rights activists. This results in the increased adoption of in vitro toxicity testing and helps in the growth of the market. Covered in this Report The Global In Vitro Toxicity Testing market can be divided into four end-user segments: Cosmetics and Personal Care Industry, Pharmaceuticals Industry, Food Industry, and Chemicals Industry. The Global In Vitro Toxicity Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the market. In addition, the report discusses the major drivers that influence the growth of the Global In Vitro Toxicity Testing market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. The report also includes a discussion of the key vendors operating in this market. Key Regions Americas EMEA APAC Key Vendors Accelrys Inc. Bio-Rad Laboratories Inc. Charles River Laboratories International Inc. Covance Inc. Purchase Report @ http://www.reportsnreports.com/purchase.aspx?name=280671. Other Prominent Vendors Entelos Inc. Mattek Corp. Molecular Toxicology Inc. RTI Health Solutions SBW Ltd. Smithers Group Inc. Xenobiotic Detection Systems Inc. Xenometrix AG Key Market Driver Increasing Opposition to Animal Testing. Key Market Challenge Concerns about Accuracy and Reliability of the Test. Key Market Trend Increase in Animal-free Testing Campaigns. Further, the report states that the accuracy and reliability of in vitro toxicity testing is one of the major challenges faced by the market vendors. In vitro toxicity testing requires proper laboratory setup as well as high-quality cell and tissue culture and good aseptic techniques. The report recognizes the following companies as the key players in Global In-vitro Toxicity Testing Market: Accelrys Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International Inc. , Covance Inc. , Entelos Inc., MattekCorp., Molecular Toxicology Inc., RTI Health Solutions, SBW Ltd., Smithers Group Inc., Xenobiotic Detection SystemsInc., Xenometrix AG. Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Accelrys® Speeds Life Science Decisions with Next-Generation Insight®
PR Newswire - Thu Apr 10, 7:00AM CDT
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software and solutions, today announced the latest releases of Accelrys Insight and Accelrys Insight for Excel. The new release of Accelrys Insight for Excel enhances scientific data analysis with important new capabilities including the ability to run database searches directly from the familiar Microsoft Excel spreadsheet environment. The new release of the web-based Accelrys Insight life science, discovery and innovation support environment speeds decisions by simplifying access to complex hierarchical data and implementing data-rich tooltips for scatterplots. The two releases continue the rapid evolution of Accelrys' next-generation solution for interactively searching, browsing and visualizing data within the Accelrys Cheminformatics Suite, helping networked life science discovery teams bring innovative therapeutics to market faster and more cost effectively. Both products leverage the open, scientifically aware Accelrys Enterprise Platform which provides a single consistent way for applications to access both internal data and public data accessible via web services.
Dassault Systemes announces extension of tender offer for Accelrys' shares until 22 April 2014
M2 - Wed Apr 09, 11:07AM CDT
Dassault Systemes (Paris
SY.PA), a provider of 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, today announced the extension of the tender offer by its wholly owned indirect subsidiary, 3DS Acquisition Corp, to purchase all outstanding shares of Accelrys Inc (Nasdaq:ACCL) common stock until midnight, New York City time of 22 April 2014, unless otherwise extended or terminated. Dassault Systemes Extends Tender Offer for Accelrys until April 22, 2014
Business Wire - Wed Apr 09, 12:19AM CDT
Regulatory News:
Shares of ACCL Up 33.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 08, 9:40AM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 7 months, Accelrys has returned 33.26% as of today's recent price of $12.48.
Biosimulation Trends - Global Market Overview 2014-2017
M2 - Thu Apr 03, 10:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bclc3f/biosimulation) has announced the addition of the "Biosimulation Trends" report to their offering. Biosimulation is the mathematical simulation of complex, large biological processes on a computer. Biosimulation is being adopted at a faster pace, to extract and interpret vital data from experiments during drug discovery and development. The report analyzes and presents an overview of Biosimulation market worldwide. The report provides global market estimates and projections for Biosimulation in US dollars for the years 2012 through 2017. Supported with 1 market data table, the report highlights the ever increasing permanence of Biosimulation. The report also provides a review of Biosimulation Models, and Biosimulation software. Key Topics Covered: 1. BIOSIMULATION - A MARKET OVERVIEW - A Prelude - Biosimulation - Revolutionizing Drug Discovery - Biosimulation - Models - Biosimulation Software 2. RECENT INDUSTRY ACTIVITY - Accelrys Introduces Discovery Studio 3.5 - Rhenovia Pharma Introduces Drug Development Programs for Orphan, Neglected and Rare Neurodegenerative Diseases - Rhenovia Pharma Sets Up International Subsidiary in the US - Rhenovia Pharma Inks an Agreement with Portmann - Entelos and RegeneMed Introduce iToxFX Service 3. MARKET PARTICIPANTS - Accelrys, Inc. - Advanced Chemistry Development, Inc. - Anoixis Corporation - Aptiv Solutions - Chemical Computing Group, Inc. - Cognigen Corporation - Compugen Ltd. - Entelos, Inc. - Genedata AG - GNS Healthcare - Immunetrics, Inc. - INOSIM Software GmbH - Insilico Biotechnology AG - Kinetigen, Inc. - LeadInvent - Leadscope, Inc. - Molecular Knowledge Systems, Inc. - Nimbus Discovery LLC - Novo Nordisk A/S - Open Eye Scientific Software, Inc. - Optimata Ltd. - PhinC Development - Physiomics PLC - Rhenovia Pharma SAS - Rosa & Company LLC - Schrodinger LLC - Simcyp Ltd. - Tessella Ltd. - TheraSim - VirtuCel, Inc. 4. APPENDIX For more information visit http://www.researchandmarkets.com/research/bc...simulation
Alliance Fiber Optic Products (AFOP) Surges: Stock Moves 12.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 8:18AM CDT
Alliance Fiber Optic Products Inc. (AFOP) was a big mover last session, as the company saw its shares rise by roughly 13% on the day.
Latin American Bioinformatics Market by Sector, Segment & Applications - Forecasts to 2017
M2 - Tue Apr 01, 8:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kss73x/latin_american) has announced the addition of the "Latin American Bioinformatics Market by Sector, Segment & Application - Forecasts to 2017" report to their offering. The Latin American bioinformatics market displays a lucrative growth potential. It is estimated to grow at a CAGR of 22% from 2012 to 2017 to reach $627 million by 2017 In Latin America, bioinformatics is now widely recognized as a crucial field for research and development in agricultural, veterinary, and human health sciences. The growth of the bioinformatics market is driven by factors such as the decreasing cost of DNA sequencing, the increasing number of training and development programs on the usage of bioinformatics tools/platforms, the high concentration of bioinformatics research institutes, ongoing partnerships of academic institutions, and the formation of regional bioinformatics networks. However, the dearth of adequate infrastructural facilities and skilled professionals, presence of obsolete bioinformatics solutions, lack of government funding and investments, and less focus of global bioinformatics players on Latin American countries are factors that are restraining the growth of the market. Based on the use of bioinformatics in various industries, the bioinformatics market is segmented into agriculture, medical, environment, forensic, academics, and others (including homeland security and defense, law-enforcement groups, bioweapon creation, antibiotic resistance, and evolutionary biotechnology). The medical biotechnology market is segmented into molecular medicine, clinical diagnostics, drug development, gene therapy, and reproductive biotechnology. On the other hand, agriculture biotechnology is segmented into crop yield improvement, insect and disease resistance, nutritional quality improvement, soil quality improvement, improvement of plant resistance against abiotic stress, and others. Furthermore, the environmental biotechnology market includes waste cleanup, alternative energy sources, climate change studies, forensics biotechnology, and others. Based on the type of products and services, the bioinformatics market is classified into knowledge management tools, platforms, and services. The bioinformatics knowledge management tools market includes generalized and specialized knowledge management tools. The bioinformatics platforms market is segmented into sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms, structural and functional analysis platforms, and others. The bioinformatics services market comprises sequencing services, database management, data analysis, and others. The bioinformatics market has several practical applications in fields that generate large data sets. In this report, the various applications of bioinformatics include genomics, proteomics, chemoinformatics, molecular phylogenies, metabolomics, transcriptomics, and others. Brazil was the largest market in 2012 with 40% share of the Latin American bioinformatics market, followed by Mexico. However, Chile and Peru represent the fastest-growing markets due to the initiatives taken by these nations with regards to skills development of researchers as well as the ongoing academic collaborations to facilitate the adoption of bioinformatics in life sciences research. The major players in the bioinformatics industry include Agilent Technologies, Inc. (U.S.), Affymetrix, Inc. (U.S.), Life Technologies Corporation (U.S.), Illumina, Inc. (U.S.), and CLC Bio (Denmark). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Latin America Bioinformatics Market, By Sectors 6 Latin America Bioinformatics Market, By Products & Services 7 Latin America Bioinformatics Market, By Applications 8 Geographic Analysis 9 Company Profiles - Accelrys, Inc. - Active Motif, Inc. - Affymetrix, Inc. - Agilent Technologies, Inc. - Clc Bio - Geneva Bioinfromatics (Genebio) Sa - Illumina, Inc. - Life Technologies Corporation - Partek, Incorporated - Perkinelmer, Inc. For more information visit http://www.researchandmarkets.com/research/ks...n_american
What Makes IntraLinks Holdings (IL) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 7:52AM CDT
IntraLinks Holdings has witnessed a significant price decline in the past four weeks. The reason is negative trend in earnings estimate revisions. The stock also has seen some pretty dismal trading lately.
Dr. David B. Agus to Present Keynote Address on the End of Illness at Accelerate2014
PR Newswire - Thu Mar 27, 4:40PM CDT
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software and solutions, today announced that David B. Agus, MD, one of the world's leading cancer doctors, researchers, medical futurists and technology innovators, will present the keynote address at the Accelrys user conference, Accelerate2014, which is being held from May 19-23 at the Grand Hyatt Washington, D.C.
Strength Seen in Elephant Talk Communications (ETAK): Stock Up 18.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 8:04AM CDT
Elephant Talk Communications Corp. was a big mover last session, as the company saw its shares rise by nearly 19% on the day.
Dassault Systemes extends offer for Accelrys
M2 - Thu Mar 27, 7:43AM CDT
Dassault Systemes (DSY.PA) said it has extended the tender offer by its subsidiary, 3DS Acquisition Corp., to purchase all outstanding shares of Accelrys, Inc. (NASDAQ: ACCL) common stock at an offer price of USD12.50 per share in cash.
33.5% Return Seen to Date on SmarTrend Accelrys Call (ACCL)
Comtex SmarTrend(R) - Mon Mar 24, 4:56PM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 6 months, Accelrys has returned 33.48% as of today's recent price of $12.50.
Biogen Idec to Present on Best Practices for Leveraging Quality and Regulatory Compliance Management Software on Apple iPads
Marketwire - Thu Mar 20, 8:00AM CDT
QUMAS, an Accelrys company (NASDAQ: ACCL), today announced that it will host a live, complimentary webinar highlighting how to save time, money, and materials and how to increase compliance across Manufacturing by leveraging QUMAS Quality and Regulatory Compliance Management Software on Apple iPads. The webinar will offer expert advice from Gregory Chua, Senior Manufacturing Support Associate at Biogen Idec and Murtuza Vasowalla, Director of Global Solutions Consulting at QUMAS.
